BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Background The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Each section has been revised or rewritten and five new sections added:(i) management of
free floating thrombus (section 4.13),(ii) management of carotid webs (section 4.14),(iii) …

Background Randomized, controlled trials have shown both benefit and harm from tight
blood-glucose control in patients in the intensive care unit (ICU). Variation in the use of early …

Intravenous thrombolysis is the only approved systemic reperfusion treatment for patients
with acute ischaemic stroke. These European Stroke Organisation (ESO) guidelines provide …

Objectives: Concise “synthetic” review of the state of the art of management of acute
ischemic stroke. Data Sources: Available literature on PubMed. Study Selection: We …

Stroke is the leading cause of long term disability in developed countries and one of the top
causes of mortality worldwide. The past decade has seen substantial advances in the …

Hemorrhagic transformation (HT) is a common complication in patients with acute ischemic
stroke. It occurs when peripheral blood extravasates across a disrupted blood brain barrier …

Hyperglycaemia in people with and without diabetes admitted to the hospital is associated
with a substantial increase in morbidity, mortality, and health-care costs. Professional …

Importance DL-3-n-butylphthalide (NBP) is a drug for treating acute ischemic stroke and may
play a neuroprotective role by acting on multiple active targets. The efficacy of NBP in …